HL7 Europe Base and Core FHIR IG
2.0.0 - trial-use 150

HL7 Europe Base and Core FHIR IG - Downloaded Version 2.0.0 See the Directory of published versions

## ValueSet: Laboratory Code

Official URL: http://hl7.eu/fhir/base/ValueSet/lab-obsCode-eu-lab | Version: 2.0.0
Active as of 2026-04-27 | Computable Name: LaboratoryResultStandardEuVs
Copyright/Legal: This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc This material contains content from NPU Terminology (http://npu-terminology.org). NPU is copyright International Federation of Clinical Chemistry (IFCC) and International Union of Pure and Applied Chemistry (IUPAC) and is available at no cost under the license at https://www.labterm.dk/.

Laboratory observation codes. List of Laboratory observation codes containing LOINC and NPU.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

### Logical Definition (CLD)

This value set includes codes based on the following rules:

- Include all codes defined in `http://loinc.org` version Not Stated (use latest from terminology server)
- Include all codes defined in `http://npu-terminology.org` version Not Stated (use latest from terminology server)

### Expansion

Expansion from tx-nordics.fhir.org, tx.fhir.org based on:

- Loinc v2.82
- codesystem Nomenclature for Properties and Units (NPU) version INT 2026-03-27

This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

System | Code | Display (en) | status | JSON | XML
`http://loinc.org` | 100000-9 | Health informatics pioneer and the father of LOINC |  |  |
`http://loinc.org` | 100001-7 | Health informatics pioneer and cofounder of LOINC |  |  |
`http://loinc.org` | 100002-5 | Specimen care is maintained |  |  |
`http://loinc.org` | 100003-3 | Team communication is maintained throughout care |  |  |
`http://loinc.org` | 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure |  |  |
`http://loinc.org` | 100005-8 | Demonstrates knowledge of nutritional management related to the procedure |  |  |
`http://loinc.org` | 100006-6 | Demonstrates knowledge of medication management |  |  |
`http://loinc.org` | 100007-4 | Demonstrates knowledge of pain management |  |  |
`http://loinc.org` | 10000-8 | R wave duration in lead AVR |  |  |
`http://loinc.org` | 100008-2 | Demonstrates knowledge of wound management |  |  |
`http://loinc.org` | 100009-0 | Demonstrates knowledge of the procedure and expected results |  |  |
`http://loinc.org` | 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation |  |  |
`http://loinc.org` | 100011-6 | No injury related to an electrical source |  |  |
`http://loinc.org` | 100012-4 | Participates in decisions affecting the patient's plan of care |  |  |
`http://loinc.org` | 100013-2 | Participates in the discharge process |  |  |
`http://loinc.org` | 100014-0 | Psychosocial health is maintained at or improved from baseline |  |  |
`http://loinc.org` | 100015-7 | No injury related to positioning due to care or procedure |  |  |
`http://loinc.org` | 10001-6 | R wave duration in lead I |  |  |
`http://loinc.org` | 100016-5 | No injury related to a laser source |  |  |
`http://loinc.org` | 100017-3 | Perioperative nursing data set outcomes panel [PNDS] |  |  |
`http://loinc.org` | 100018-1 | Hospice care Note |  |  |
`http://loinc.org` | 100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 10002-4 | R wave duration in lead II |  |  |
`http://loinc.org` | 100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |  |  |
`http://loinc.org` | 100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] |  |  |
`http://loinc.org` | 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] |  |  |
`http://loinc.org` | 10003-2 | R wave duration in lead III |  |  |
`http://loinc.org` | 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] |  |  |
`http://loinc.org` | 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |  |  |
`http://loinc.org` | 100034-8 | Provider of automated external defibrillator use |  |  |
`http://loinc.org` | 100035-5 | Exam finding location of Chest |  |  |
`http://loinc.org` | 100036-3 | Exam finding location of Lung |  |  |
`http://loinc.org` | 100037-1 | Patient contact disposition EMS unit |  |  |
`http://loinc.org` | 100038-9 | Patient evaluation disposition EMS unit |  |  |
`http://loinc.org` | 100039-7 | Crew disposition for patient care EMS unit |  |  |
`http://loinc.org` | 10004-0 | R wave duration in lead V1 |  |  |
`http://loinc.org` | 100040-5 | Patient transport disposition EMS unit |  |  |
`http://loinc.org` | 100041-3 | Aminoglycoside [Susceptibility] |  |  |
`http://loinc.org` | 100042-1 | Atovaquone [Susceptibility] |  |  |
`http://loinc.org` | 100043-9 | Azithromycin+Ethambutol [Susceptibility] |  |  |
`http://loinc.org` | 100044-7 | Cefcapene [Susceptibility] |  |  |
`http://loinc.org` | 100045-4 | Cefozopran [Susceptibility] |  |  |
`http://loinc.org` | 100046-2 | Cefquinome [Susceptibility] |  |  |
`http://loinc.org` | 100047-0 | Cefteram [Susceptibility] |  |  |
`http://loinc.org` | 100048-8 | Clarithromycin+Ethambutol [Susceptibility] |  |  |
`http://loinc.org` | 100049-6 | Eravacycline [Susceptibility] |  |  |
`http://loinc.org` | 100050-4 | Erythromycin+Ethambutol [Susceptibility] |  |  |
`http://loinc.org` | 100051-2 | Ethambutol+rifAMPin [Susceptibility] |  |  |
`http://loinc.org` | 100052-0 | Flomoxef [Susceptibility] |  |  |
`http://loinc.org` | 100053-8 | Fluoroquinolone [Susceptibility] |  |  |
`http://loinc.org` | 100054-6 | Gamithromycin [Susceptibility] |  |  |
`http://loinc.org` | 100055-3 | Optochin [Susceptibility] |  |  |
`http://loinc.org` | 100056-1 | Panipenem [Susceptibility] |  |  |
`http://loinc.org` | 10005-7 | R wave duration in lead V2 |  |  |
`http://loinc.org` | 100057-9 | Prothionamide [Susceptibility] |  |  |
`http://loinc.org` | 100058-7 | Prulifloxacin [Susceptibility] |  |  |
`http://loinc.org` | 100059-5 | Rifapentine [Susceptibility] |  |  |
`http://loinc.org` | 100060-3 | Tildipirosin [Susceptibility] |  |  |
`http://loinc.org` | 100061-1 | Tosufloxacin [Susceptibility] |  |  |
`http://loinc.org` | 100062-9 | Standard Dermatology Outcome Measures panel |  |  |
`http://loinc.org` | 100063-7 | Primary skin concern |  |  |
`http://loinc.org` | 100064-5 | Itch severity Reporting Period - Reported |  |  |
`http://loinc.org` | 10006-5 | R wave duration in lead V3 |  |  |
`http://loinc.org` | 100065-2 | Satisfied with treatment |  |  |
`http://loinc.org` | 100066-0 | Specular microscopy panel | TRIAL |  |
`http://loinc.org` | 100067-8 | Eye Image magnification | TRIAL |  |
`http://loinc.org` | 100068-6 | Right eye Fixation point [Angle] | TRIAL |  |
`http://loinc.org` | 100069-4 | Left eye Fixation point [Angle] | TRIAL |  |
`http://loinc.org` | 100070-2 | Right cornea Cell density | TRIAL |  |
`http://loinc.org` | 100071-0 | Left cornea Cell density | TRIAL |  |
`http://loinc.org` | 100072-8 | Right cornea Coefficient of variation | TRIAL |  |
`http://loinc.org` | 10007-3 | R wave duration in lead V4 |  |  |
`http://loinc.org` | 100073-6 | Left cornea Coefficient of variation | TRIAL |  |
`http://loinc.org` | 100074-4 | Right cornea Hexagonality | TRIAL |  |
`http://loinc.org` | 100075-1 | Left cornea Hexagonality | TRIAL |  |
`http://loinc.org` | 100076-9 | Right cornea Endothelial cells counted | TRIAL |  |
`http://loinc.org` | 100077-7 | Left cornea Endothelial cells counted | TRIAL |  |
`http://loinc.org` | 100078-5 | Right cornea Endothelial cell area.min | TRIAL |  |
`http://loinc.org` | 100079-3 | Left cornea Endothelial cell area.min | TRIAL |  |
`http://loinc.org` | 100080-1 | Right cornea Endothelial cell area.max | TRIAL |  |
`http://loinc.org` | 10008-1 | R wave duration in lead V5 |  |  |
`http://loinc.org` | 100081-9 | Left cornea Endothelial cell area.max | TRIAL |  |
`http://loinc.org` | 100082-7 | Right cornea Endothelial cell area.mean | TRIAL |  |
`http://loinc.org` | 100083-5 | Left cornea Endothelial cell area.mean | TRIAL |  |
`http://loinc.org` | 100084-3 | Right cornea Cell area.standard deviation | TRIAL |  |
`http://loinc.org` | 100085-0 | Left cornea Cell area.standard deviation | TRIAL |  |
`http://loinc.org` | 100086-8 | Right cornea Type of Analysis method by Specular microscopy | TRIAL |  |
`http://loinc.org` | 100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit |  |  |
`http://loinc.org` | 100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 10009-9 | R wave duration in lead V6 |  |  |
`http://loinc.org` | 100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100105-6 | Filaria IgG and IgM panel - Serum |  |  |
`http://loinc.org` | 100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 10010-7 | R' wave amplitude in lead AVF |  |  |
`http://loinc.org` | 100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100113-0 | Helicobacter pylori Ab panel - Serum |  |  |
`http://loinc.org` | 100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 10011-5 | R' wave amplitude in lead AVL |  |  |
`http://loinc.org` | 100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100120-5 | Chlamydia trachomatis Ab panel - Serum |  |  |
`http://loinc.org` | 100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100122-1 | Chlamydophila pneumoniae Ab panel - Serum |  |  |
`http://loinc.org` | 10012-3 | R' wave amplitude in lead AVR |  |  |
`http://loinc.org` | 100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100125-4 | Chlamydophila psittaci Ab panel - Serum |  |  |
`http://loinc.org` | 100126-2 | Bordetella pertussis Ab.IgG panel - Serum |  |  |
`http://loinc.org` | 100127-0 | Campylobacter sp Ab panel - Serum |  |  |
`http://loinc.org` | 100128-8 | Cryptococcus sp Ag panel - Serum |  |  |
`http://loinc.org` | 100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |  |  |
`http://loinc.org` | 100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 10013-1 | R' wave amplitude in lead I |  |  |
`http://loinc.org` | 100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |  |  |
`http://loinc.org` | 100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot |  |  |
`http://loinc.org` | 10014-9 | R' wave amplitude in lead II |  |  |
`http://loinc.org` | 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |  |  |
`http://loinc.org` | 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |  |  |
`http://loinc.org` | 100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |  |  |
`http://loinc.org` | 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |  |  |
`http://loinc.org` | 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |  |  |
`http://loinc.org` | 100154-4 | Specimen collection supervision level |  |  |
`http://loinc.org` | 100155-1 | Left cornea Type of Analysis method by Specular microscopy | TRIAL |  |
`http://loinc.org` | 10015-6 | R' wave amplitude in lead III |  |  |
`http://loinc.org` | 100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |  |  |
`http://loinc.org` | 100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration |  |  |
`http://loinc.org` | 100159-3 | Knee Society Score pre-op panel [Knee Society Score] |  |  |
`http://loinc.org` | 100160-1 | Knee replacement |  |  |
`http://loinc.org` | 100161-9 | Charnley Functional Classification |  |  |
`http://loinc.org` | 100162-7 | Knee alignment W standing X-ray measured |  |  |
`http://loinc.org` | 100163-5 | Knee medial AndOr lateral instability W full extension |  |  |
`http://loinc.org` | 10016-4 | R' wave amplitude in lead V1 |  |  |
`http://loinc.org` | 100164-3 | Knee AP instability W 90 degree flexion |  |  |
`http://loinc.org` | 100165-0 | Knee range of motion |  |  |
`http://loinc.org` | 100166-8 | Flexion contracture range of Knee |  |  |
`http://loinc.org` | 100167-6 | Extensor lag range of Knee |  |  |
`http://loinc.org` | 100168-4 | Knee pain severity with level walking |  |  |
`http://loinc.org` | 100169-2 | Knee pain severity with stairs or inclines |  |  |
`http://loinc.org` | 1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor |  |  |
`http://loinc.org` | 100170-0 | Knee feels normal |  |  |
`http://loinc.org` | 100171-8 | Satisfaction with level of knee pain while sitting |  |  |
`http://loinc.org` | 10017-2 | R' wave amplitude in lead V2 |  |  |
`http://loinc.org` | 100172-6 | Satisfaction with level of knee pain while lying in bed |  |  |
`http://loinc.org` | 100173-4 | Satisfaction with knee function while getting out of bed |  |  |
`http://loinc.org` | 100174-2 | Satisfaction with knee function while performing light household duties |  |  |
`http://loinc.org` | 100175-9 | Satisfaction with knee function while performing recreational activities |  |  |
`http://loinc.org` | 100176-7 | Expect surgery to relieve pain |  |  |
`http://loinc.org` | 100177-5 | Expect surgery will improve ability to perform activities of daily living |  |  |
`http://loinc.org` | 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities |  |  |
`http://loinc.org` | 100179-1 | Walk without assistive mobility devices |  |  |
`http://loinc.org` | 10018-0 | R' wave amplitude in lead V3 |  |  |
`http://loinc.org` | 100180-9 | Assistive mobility devices used |  |  |
`http://loinc.org` | 100181-7 | Assistive mobility devices used due to health condition |  |  |
`http://loinc.org` | 100182-5 | Duration of standing before sitting due to knee discomfort |  |  |
`http://loinc.org` | 100183-3 | Duration of walking before stopping due to knee discomfort |  |  |
`http://loinc.org` | 100184-1 | How bothersome is knee when walking on an uneven surface |  |  |
`http://loinc.org` | 100185-8 | How bothersome is knee when turning or pivoting leg |  |  |
`http://loinc.org` | 100186-6 | How bothersome is knee when climbing up or down a flight of stairs |  |  |
`http://loinc.org` | 100187-4 | How bothersome is knee when getting up from a low seat without armrests |  |  |
`http://loinc.org` | 100188-2 | How bothersome is knee when getting into or out of a car |  |  |
`http://loinc.org` | 100189-0 | How bothersome is knee when moving laterally |  |  |
`http://loinc.org` | 100190-8 | How bothersome is knee when climbing a ladder or step stool |  |  |
`http://loinc.org` | 100191-6 | How bothersome is knee when carrying a bag for one block |  |  |
`http://loinc.org` | 100192-4 | How bothersome is knee when squatting |  |  |
`http://loinc.org` | 100193-2 | How bothersome is knee when kneeling |  |  |
`http://loinc.org` | 100194-0 | How bothersome is knee when running |  |  |
`http://loinc.org` | 100195-7 | Pain severity--during activity |  |  |
`http://loinc.org` | 100196-5 | Pre-op total score [Knee Society Score] |  |  |
`http://loinc.org` | 100197-3 | Exercise activity and pain severity panel |  |  |
`http://loinc.org` | 10019-8 | R' wave amplitude in lead V4 |  |  |
`http://loinc.org` | 100198-1 | Pre-op objective knee indicators score [Knee Society Score] |  |  |
`http://loinc.org` | 100199-9 | Pre-op symptoms score [Knee Society Score] |  |  |
`http://loinc.org` | 100200-5 | Pre-op patient expectations score [Knee Society Score] |  |  |
`http://loinc.org` | 100201-3 | Pre-op functional activities score [Knee Society Score] |  |  |
`http://loinc.org` | 100202-1 | Pre-op discretionary knee activities score [Knee Society Score] |  |  |
`http://loinc.org` | 100203-9 | Knee Society Score post-op panel [Knee Society Score] |  |  |
`http://loinc.org` | 100204-7 | Accuracy of pre-surgery expectations of pain relief |  |  |
`http://loinc.org` | 100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living |  |  |
`http://loinc.org` | 10020-6 | R' wave amplitude in lead V5 |  |  |
`http://loinc.org` | 100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities |  |  |
`http://loinc.org` | 100207-0 | Post-op total score [Knee Society Score] |  |  |
`http://loinc.org` | 100208-8 | Post-op objective knee indicators score [Knee Society Score] |  |  |
`http://loinc.org` | 100209-6 | Post-op symptoms score [Knee Society Score] |  |  |
`http://loinc.org` | 100210-4 | Post-op patient expectations score [Knee Society Score] |  |  |
`http://loinc.org` | 100211-2 | Post-op functional activities score [Knee Society Score] |  |  |
`http://loinc.org` | 100212-0 | Post-op discretionary knee activities score [Knee Society Score] |  |  |
`http://loinc.org` | 100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method |  |  |
`http://loinc.org` | 10021-4 | R' wave amplitude in lead V6 |  |  |
`http://loinc.org` | 100214-6 | Dental model prior authorization Document |  |  |
`http://loinc.org` | 100215-3 | Episode of care medical records Document Transplant surgery |  |  |
`http://loinc.org` | 100216-1 | Surgical synoptic report |  |  |
`http://loinc.org` | 100217-9 | Synoptic report Document Surgical oncology |  |  |
`http://loinc.org` | 100218-7 | Surgical oncology of colon cancer synoptic report |  |  |
`http://loinc.org` | 100219-5 | Surgical oncology of melanoma cancer synoptic report |  |  |
`http://loinc.org` | 100220-3 | Surgical oncology of breast cancer synoptic report |  |  |
`http://loinc.org` | 100221-1 | Surgical oncology of thyroid cancer synoptic report |  |  |
`http://loinc.org` | 10022-2 | R' wave duration in lead AVF |  |  |
`http://loinc.org` | 100222-9 | Surgical oncology of pancreas cancer synoptic report |  |  |
`http://loinc.org` | 100223-7 | Physical findings of Retina Narrative |  |  |
`http://loinc.org` | 100224-5 | Cardiac left ventricular segmental wall motion by echo panel |  |  |
`http://loinc.org` | 100225-2 | Bone density quantitative ultrasound study |  |  |
`http://loinc.org` | 100226-0 | Small bowel capsule endoscopy study Document |  |  |
`http://loinc.org` | 100227-8 | Colon capsule endoscopy study Document |  |  |
`http://loinc.org` | 100228-6 | Upper gastrointestinal capsule endoscopy study Document |  |  |
`http://loinc.org` | 100229-4 | Endoscopic ultrasound study Document |  |  |
`http://loinc.org` | 10023-0 | R' wave duration in lead AVL |  |  |
`http://loinc.org` | 100230-2 | Routine prenatal assessment panel |  |  |
`http://loinc.org` | 100231-0 | Endobronchial ultrasound study |  |  |
`http://loinc.org` | 100232-8 | Impacts of Events Scale-Revised panel |  |  |
`http://loinc.org` | 100233-6 | Reminders brought back feelings about adverse event |  |  |
`http://loinc.org` | 100234-4 | Trouble staying asleep |  |  |
`http://loinc.org` | 100235-1 | Other things triggered persistent thoughts about adverse event |  |  |
`http://loinc.org` | 100236-9 | Felt irritable AndOr angry |  |  |
`http://loinc.org` | 100237-7 | Avoided getting upset when unintentionally thought about adverse event |  |  |
`http://loinc.org` | 100238-5 | Thought about adverse event unintentionally |  |  |
`http://loinc.org` | 100239-3 | Felt as if adverse event did not happen |  |  |
`http://loinc.org` | 100240-1 | Avoided reminders of adverse event |  |  |
`http://loinc.org` | 100241-9 | Experienced mental images of adverse event |  |  |
`http://loinc.org` | 100242-7 | Easily startled |  |  |
`http://loinc.org` | 100243-5 | Tried to not think of adverse event |  |  |
`http://loinc.org` | 100244-3 | Aware of feelings about adverse event, but did not address them |  |  |
`http://loinc.org` | 100245-0 | Feelings about adverse event were numb |  |  |
`http://loinc.org` | 100246-8 | Acted or felt the same as during adverse event |  |  |
`http://loinc.org` | 100247-6 | Trouble falling asleep |  |  |
`http://loinc.org` | 10024-8 | R' wave duration in lead AVR |  |  |
`http://loinc.org` | 100248-4 | Waves of strong feelings about adverse event |  |  |
`http://loinc.org` | 100249-2 | Tried to remove adverse event from memory |  |  |
`http://loinc.org` | 1002-5 | DBG Ab [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100250-0 | Trouble concentrating |  |  |
`http://loinc.org` | 100251-8 | Reminders of adverse event caused physical reactions |  |  |
`http://loinc.org` | 100252-6 | Had dreams about adverse event |  |  |
`http://loinc.org` | 100253-4 | Felt watchful and on-guard |  |  |
`http://loinc.org` | 100254-2 | Tried not to talk about adverse event |  |  |
`http://loinc.org` | 10025-5 | R' wave duration in lead I |  |  |
`http://loinc.org` | 100255-9 | Total score [Impact of Event Scale-Revised] |  |  |
`http://loinc.org` | 100256-7 | Fallen in last 6 months |  |  |
`http://loinc.org` | 100257-5 | Feel unsteady when standing or walking |  |  |
`http://loinc.org` | 100258-3 | History of fall related injury |  |  |
`http://loinc.org` | 100259-1 | Aware of tactile sensations |  |  |
`http://loinc.org` | 100260-9 | Easy to describe thoughts AndOr feelings |  |  |
`http://loinc.org` | 100261-7 | Critical of own thoughts AndOr feelings |  |  |
`http://loinc.org` | 100262-5 | Able to notice distressing thoughts AndOr feelings without having to react |  |  |
`http://loinc.org` | 10026-3 | R' wave duration in lead II |  |  |
`http://loinc.org` | 100263-3 | Easily distracted |  |  |
`http://loinc.org` | 100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed |  |  |
`http://loinc.org` | 100265-8 | Aware of dietary intake impact on self |  |  |
`http://loinc.org` | 100266-6 | Difficult to describe thoughts AndOr feelings |  |  |
`http://loinc.org` | 100267-4 | Aware of auditory stimuli |  |  |
`http://loinc.org` | 100268-2 | Able to avoid immediate reaction in difficult situations |  |  |
`http://loinc.org` | 100269-0 | Do things without paying attention |  |  |
`http://loinc.org` | 100270-8 | Recover quickly from distressing thoughts AndOr images |  |  |
`http://loinc.org` | 10027-1 | R' wave duration in lead III |  |  |
`http://loinc.org` | 100271-6 | Aware of olfactory stimuli |  |  |
`http://loinc.org` | 100272-4 | Aware of visual stimuli |  |  |
`http://loinc.org` | 100273-2 | Aware of emotions affect on thoughts AndOr behavior |  |  |
`http://loinc.org` | 100274-0 | Observing score [FFMQ] |  |  |
`http://loinc.org` | 100275-7 | Describing score [FFMQ] |  |  |
`http://loinc.org` | 100276-5 | Acting with awareness score [FFMQ] |  |  |
`http://loinc.org` | 100277-3 | Nonjudging score [FFMQ] |  |  |
`http://loinc.org` | 100278-1 | Nonreactivity score [FFMQ] |  |  |
`http://loinc.org` | 100279-9 | Total score [FFMQ] |  |  |
`http://loinc.org` | 100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] |  |  |
`http://loinc.org` | 100281-5 | D Ab [Units/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100282-3 | Vaccine exemption certificate |  |  |
`http://loinc.org` | 100283-1 | Harris Hip Score panel [Harris Hip Score] |  |  |
`http://loinc.org` | 100284-9 | Walking - functional ability |  |  |
`http://loinc.org` | 100285-6 | Comfortable seated position |  |  |
`http://loinc.org` | 100286-4 | Able to board public transportation |  |  |
`http://loinc.org` | 100287-2 | Put on shoes and socks |  |  |
`http://loinc.org` | 100288-0 | Absence of deformity score [Harris Hip Score] |  |  |
`http://loinc.org` | 10028-9 | R' wave duration in lead V1 |  |  |
`http://loinc.org` | 100289-8 | Absence of hip deformity measurements |  |  |
`http://loinc.org` | 100290-6 | Range of motion score [Harris Hip Score] |  |  |
`http://loinc.org` | 100291-4 | Total score [Harris Hip Score] |  |  |
`http://loinc.org` | 100292-2 | Pre-op patient satisfaction score [Knee Society Score] |  |  |
`http://loinc.org` | 100293-0 | Hip Flexion range of motion |  |  |
`http://loinc.org` | 100294-8 | Hip Abduction range of motion |  |  |
`http://loinc.org` | 100295-5 | Hip Adduction range of motion |  |  |
`http://loinc.org` | 100296-3 | Hip External rotation range of motion |  |  |
`http://loinc.org` | 10029-7 | R' wave duration in lead V2 |  |  |
`http://loinc.org` | 100297-1 | Hip Internal rotation range of motion |  |  |
`http://loinc.org` | 100298-9 | Repetition count |  |  |
`http://loinc.org` | 100299-7 | Post-op patient satisfaction score [Knee Society Score] |  |  |
`http://loinc.org` | 100300-3 | End time Unspecified body region |  |  |
`http://loinc.org` | 100301-1 | Start time Unspecified body region |  |  |
`http://loinc.org` | 100302-9 | Time period start and end panel Unspecified body region |  |  |
`http://loinc.org` | 100303-7 | Condition certainty of presence |  |  |
`http://loinc.org` | 100304-5 | Flights climbed [#] Reporting Period |  |  |
`http://loinc.org` | 10030-5 | R' wave duration in lead V3 |  |  |
`http://loinc.org` | 100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |  |  |
`http://loinc.org` | 100306-0 | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |  |  |
`http://loinc.org` | 100307-8 | Behavioral screening elder mistreatment |  |  |
`http://loinc.org` | 100308-6 | Need help getting to essential places |  |  |
`http://loinc.org` | 100309-4 | Activity support person |  |  |
`http://loinc.org` | 100310-2 | Reliability of support person |  |  |
`http://loinc.org` | 100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house |  |  |
`http://loinc.org` | 100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house |  |  |
`http://loinc.org` | 10031-3 | R' wave duration in lead V4 |  |  |
`http://loinc.org` | 100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day |  |  |
`http://loinc.org` | 100314-4 | Need help with house cleaning or yard work |  |  |
`http://loinc.org` | 100315-1 | Need help getting out of bed, showered, or dressed |  |  |
`http://loinc.org` | 100316-9 | Need help to make sure bills get paid |  |  |
`http://loinc.org` | 100317-7 | Relationship of usual support person for daily activities |  |  |
`http://loinc.org` | 100318-5 | Have help with finances AndOr financial decisions |  |  |
`http://loinc.org` | 100319-3 | Relationship of financial support person |  |  |
`http://loinc.org` | 100320-1 | Financial support person usually asks for permission before making decisions |  |  |
`http://loinc.org` | 10032-1 | R' wave duration in lead V5 |  |  |
`http://loinc.org` | 100321-9 | Financial support person usually makes good decisions about finances |  |  |
`http://loinc.org` | 100322-7 | Have access to paperwork for financial decisions made |  |  |
`http://loinc.org` | 100323-5 | Financial support person forged signature |  |  |
`http://loinc.org` | 100324-3 | Coercion of financial support person for signing a document in order to get money or possessions |  |  |
`http://loinc.org` | 100325-0 | Experienced theft by support person |  |  |
`http://loinc.org` | 100326-8 | Money spent or property sold without permission |  |  |
`http://loinc.org` | 100327-6 | Stranger forged signature for financial gain |  |  |
`http://loinc.org` | 100328-4 | Stranger forced document signature for financial gain |  |  |
`http://loinc.org` | 100329-2 | Feared for safety due to verbal attack |  |  |
`http://loinc.org` | 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100330-0 | Felt humiliated due to ridicule |  |  |
`http://loinc.org` | 100331-8 | Coerced to do something |  |  |
`http://loinc.org` | 100332-6 | Ignored by close friend or relative for extended period |  |  |
`http://loinc.org` | 100333-4 | Physically hit or threatened |  |  |
`http://loinc.org` | 100334-2 | Been physically hurt with some degree of injury |  |  |
`http://loinc.org` | 100335-9 | Coerced sexual activity |  |  |
`http://loinc.org` | 100336-7 | Coerced touching of private body parts of self or others |  |  |
`http://loinc.org` | 100337-5 | Coerced to undress or expose private body area |  |  |
`http://loinc.org` | 100338-3 | Photographed in any degree of nudity without consent |  |  |
`http://loinc.org` | 10033-9 | R' wave duration in lead V6 |  |  |
`http://loinc.org` | 100339-1 | Experienced attempted physical restraint |  |  |
`http://loinc.org` | 100340-9 | Range of motion panel Hip |  |  |
`http://loinc.org` | 100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |  |  |
`http://loinc.org` | 100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |  |  |
`http://loinc.org` | 100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |  |  |
`http://loinc.org` | 100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |  |  |
`http://loinc.org` | 100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100346-6 | Clotting time of Blood by Thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibited |  |  |
`http://loinc.org` | 10034-7 | S wave amplitude in lead AVF |  |  |
`http://loinc.org` | 100347-4 | Clot formation [Time] in Blood by Thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibited |  |  |
`http://loinc.org` | 100348-2 | Model for end-stage liver disease sodium score |  |  |
`http://loinc.org` | 100349-0 | US.doppler Penis vessels W vasodilator IV |  |  |
`http://loinc.org` | 100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100351-6 | Pioglitazone [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100352-4 | Rosiglitazone [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100353-2 | Norwalk Community Health Center Screening Tool [NCHC] |  |  |
`http://loinc.org` | 10035-4 | S wave amplitude in lead AVL |  |  |
`http://loinc.org` | 100354-0 | Frequency of participating in multi-modal communication without assistance |  |  |
`http://loinc.org` | 100355-7 | Frequency of participating in spoken language expression communication without assistance |  |  |
`http://loinc.org` | 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100357-3 | Naloxone [Presence] in Cord tissue by Screen method |  |  |
`http://loinc.org` | 100358-1 | Phentermine [Presence] in Cord tissue by Screen method |  |  |
`http://loinc.org` | 100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |  |  |
`http://loinc.org` | 100360-7 | Brief Resilience Scale panel [BRS] |  |  |
`http://loinc.org` | 100361-5 | Quickly recover from bad events |  |  |
`http://loinc.org` | 10036-2 | S wave amplitude in lead AVR |  |  |
`http://loinc.org` | 100362-3 | Difficulty making it through stressful events |  |  |
`http://loinc.org` | 100363-1 | Easily recover from a stressful event |  |  |
`http://loinc.org` | 100364-9 | Difficulty recovering from bad events |  |  |
`http://loinc.org` | 100365-6 | Easily recover from difficulties |  |  |
`http://loinc.org` | 100366-4 | Lengthy recovery from setbacks |  |  |
`http://loinc.org` | 100367-2 | Total Score BRS |  |  |
`http://loinc.org` | 100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |  |  |
`http://loinc.org` | 100369-8 | NM Thyroid gland Views W Tl-201 IV |  |  |
`http://loinc.org` | 10037-0 | S wave amplitude in lead I |  |  |
`http://loinc.org` | 100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100372-2 | Abiraterone [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100373-0 | Eucheuma IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100374-8 | Aloe vera IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100375-5 | Anise IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100376-3 | Bamboo sprouts IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100377-1 | Goat cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100379-7 | Leeks IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100380-5 | Red cabbage IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100381-3 | Peppermint IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100382-1 | FDA package insert REMS addressed risk |  |  |
`http://loinc.org` | 100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100384-7 | Turnip IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100385-4 | Corn salad IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100386-2 | Rosemary IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10038-8 | S wave amplitude in lead II |  |  |
`http://loinc.org` | 100388-8 | Cocoa IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100389-6 | Pistachio IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100391-2 | Dates IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100392-0 | Duck meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100394-6 | Astacoidea IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100395-3 | Carob IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10039-6 | S wave amplitude in lead III |  |  |
`http://loinc.org` | 100396-1 | Rapeseed IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100397-9 | Goat Meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100398-7 | Goose meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100400-1 | Quail meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100402-7 | Venison meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100403-5 | Guineafowl IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10040-4 | S wave amplitude in lead V1 |  |  |
`http://loinc.org` | 100404-3 | Horse meat IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100405-0 | Kefir IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100406-8 | Butter IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100409-2 | Processed cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |  |  |
`http://loinc.org` | 100410-0 | Curd cheese IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10041-2 | S wave amplitude in lead V2 |  |  |
`http://loinc.org` | 100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100414-2 | Gourd IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100415-9 | Kale IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100418-3 | Liquorice IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100419-1 | Snow pea IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 10042-0 | S wave amplitude in lead V3 |  |  |
`http://loinc.org` | 100420-9 | Fava bean IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100421-7 | Chickpea IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100422-5 | Common Chicory IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitake + chanterelle mushroom) IgG Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100426-6 | Squalene [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100428-2 | Carnitine free and total and acylcarnitine panel - Urine |  |  |
`http://loinc.org` | 100429-0 | LRBA deficiency panel - Blood |  |  |
`http://loinc.org` | 100430-8 | Cells.LRBA+/Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100432-4 | Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method |  |  |
`http://loinc.org` | 10043-8 | S wave amplitude in lead V4 |  |  |
`http://loinc.org` | 100438-1 | Adolescent medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100439-9 | Allergy and Immunology Outpatient Progress note |  |  |
`http://loinc.org` | 100440-7 | Allergy Outpatient Progress note |  |  |
`http://loinc.org` | 100441-5 | Attending Outpatient Progress note |  |  |
`http://loinc.org` | 100442-3 | Audiology Outpatient Progress note |  |  |
`http://loinc.org` | 100443-1 | Bariatric surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100444-9 | Blood banking and transfusion medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100445-6 | Bone Marrow Transplant Outpatient Progress note |  |  |
`http://loinc.org` | 10044-6 | S wave amplitude in lead V5 |  |  |
`http://loinc.org` | 100446-4 | Breastfeeding Outpatient Progress note |  |  |
`http://loinc.org` | 100447-2 | Burn management Outpatient Progress note |  |  |
`http://loinc.org` | 100448-0 | Cardiac surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100449-8 | Cardiopulmonary Outpatient Progress note |  |  |
`http://loinc.org` | 100450-6 | Child and adolescent psychiatry Outpatient Progress note |  |  |
`http://loinc.org` | 100451-4 | Chiropractic medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100452-2 | Clinical cardiac electrophysiology Outpatient Progress note |  |  |
`http://loinc.org` | 10045-3 | S wave amplitude in lead V6 |  |  |
`http://loinc.org` | 100453-0 | Clinical genetics Outpatient Progress note |  |  |
`http://loinc.org` | 100454-8 | Clinical neurophysiology Outpatient Progress note |  |  |
`http://loinc.org` | 100455-5 | Clinical pathology Outpatient Progress note |  |  |
`http://loinc.org` | 100456-3 | Colon and rectal surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100457-1 | Consultant Outpatient Progress note |  |  |
`http://loinc.org` | 100458-9 | Outpatient COVID-19 Intubation Progress note |  |  |
`http://loinc.org` | 100459-7 | Outpatient COVID-19 Progress note |  |  |
`http://loinc.org` | 100460-5 | Dermatology Outpatient Progress note |  |  |
`http://loinc.org` | 10046-1 | S wave duration in lead AVF |  |  |
`http://loinc.org` | 100461-3 | Developmental-behavioral pediatrics Outpatient Progress note |  |  |
`http://loinc.org` | 100462-1 | Dialysis and Therapeutic apheresis Outpatient Progress note |  |  |
`http://loinc.org` | 100463-9 | Eating disorders Outpatient Progress note |  |  |
`http://loinc.org` | 100464-7 | Endocrinology Outpatient Progress note |  |  |
`http://loinc.org` | 100465-4 | Family medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100466-2 | Gastroenterology Outpatient Progress note |  |  |
`http://loinc.org` | 100467-0 | Geriatric medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100468-8 | Gynecologic oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100469-6 | Gynecology Outpatient Progress note |  |  |
`http://loinc.org` | 100470-4 | Healthcare navigator Outpatient Progress note |  |  |
`http://loinc.org` | 100471-2 | Heart failure Outpatient Progress note |  |  |
`http://loinc.org` | 100472-0 | Heart failure+Transplant cardiology Outpatient Progress note |  |  |
`http://loinc.org` | 100473-8 | Hematology Outpatient Progress note |  |  |
`http://loinc.org` | 100474-6 | Hematology+Medical oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100475-3 | Hepatology Outpatient Progress note |  |  |
`http://loinc.org` | 100476-1 | Immunology Outpatient Progress note |  |  |
`http://loinc.org` | 100477-9 | Infectious disease Outpatient Progress note |  |  |
`http://loinc.org` | 100478-7 | Internal medicine Outpatient Progress note |  |  |
`http://loinc.org` | 10047-9 | S wave duration in lead AVL |  |  |
`http://loinc.org` | 100479-5 | Interventional cardiology Outpatient Progress note |  |  |
`http://loinc.org` | 100480-3 | Interventional radiology Outpatient Progress note |  |  |
`http://loinc.org` | 100481-1 | Outpatient Mechanical circulatory support Progress note |  |  |
`http://loinc.org` | 100482-9 | Medical Aid in Dying Outpatient Progress note |  |  |
`http://loinc.org` | 100483-7 | Mental health Outpatient Progress note |  |  |
`http://loinc.org` | 100484-5 | Multi-specialty program Outpatient Progress note |  |  |
`http://loinc.org` | 100485-2 | Neonatal perinatal medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100486-0 | Nephrology Outpatient Progress note |  |  |
`http://loinc.org` | 10048-7 | S wave duration in lead AVR |  |  |
`http://loinc.org` | 100487-8 | Neurological surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100488-6 | Neurology Outpatient Progress note |  |  |
`http://loinc.org` | 100489-4 | Neurology with special qualifications in child neurology Outpatient Progress note |  |  |
`http://loinc.org` | 100490-2 | Nurse practitioner Outpatient Progress note |  |  |
`http://loinc.org` | 100491-0 | Nurse Outpatient Progress note |  |  |
`http://loinc.org` | 100492-8 | Nutrition and dietetics Outpatient Progress note |  |  |
`http://loinc.org` | 100493-6 | Obstetrics and Gynecology Outpatient Progress note |  |  |
`http://loinc.org` | 100494-4 | Obstetrics Outpatient Progress note |  |  |
`http://loinc.org` | 10049-5 | S wave duration in lead I |  |  |
`http://loinc.org` | 100495-1 | Occupational therapy Outpatient Progress note |  |  |
`http://loinc.org` | 100496-9 | Oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100497-7 | Ophthalmology Outpatient Progress note |  |  |
`http://loinc.org` | 100498-5 | Optometry Outpatient Progress note |  |  |
`http://loinc.org` | 100499-3 | Oral and Maxillofacial Surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100500-8 | Orthopaedic surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100501-6 | Orthotics prosthetics Outpatient Progress note |  |  |
`http://loinc.org` | 100502-4 | Otolaryngology Outpatient Progress note |  |  |
`http://loinc.org` | 10050-3 | S wave duration in lead II |  |  |
`http://loinc.org` | 100503-2 | Pain medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100504-0 | Palliative care Outpatient Progress note |  |  |
`http://loinc.org` | 100505-7 | Pediatric cardiology Outpatient Progress note |  |  |
`http://loinc.org` | 100506-5 | Pediatric dermatology Outpatient Progress note |  |  |
`http://loinc.org` | 100507-3 | Pediatric endocrinology Outpatient Progress note |  |  |
`http://loinc.org` | 100508-1 | Pediatric gastroenterology Outpatient Progress note |  |  |
`http://loinc.org` | 100509-9 | Pediatric hematology-oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100510-7 | Pediatric infectious diseases Outpatient Progress note |  |  |
`http://loinc.org` | 10051-1 | S wave duration in lead III |  |  |
`http://loinc.org` | 100511-5 | Pediatric otolaryngology Outpatient Progress note |  |  |
`http://loinc.org` | 100512-3 | Pediatric pulmonology Outpatient Progress note |  |  |
`http://loinc.org` | 100513-1 | Pediatric rheumatology Outpatient Progress note |  |  |
`http://loinc.org` | 100514-9 | Pediatric surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100515-6 | Pediatric transplant hepatology Outpatient Progress note |  |  |
`http://loinc.org` | 100516-4 | Pediatric urology Outpatient Progress note |  |  |
`http://loinc.org` | 100517-2 | Pharmacogenomics Outpatient Progress note |  |  |
`http://loinc.org` | 100518-0 | Physical medicine and rehab Outpatient Progress note |  |  |
`http://loinc.org` | 100519-8 | Physical therapy Outpatient Progress note |  |  |
`http://loinc.org` | 100520-6 | Plastic surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100521-4 | Podiatry Outpatient Progress note |  |  |
`http://loinc.org` | 100522-2 | Psychiatry Hospital Progress note |  |  |
`http://loinc.org` | 100523-0 | Psychology Outpatient Progress note |  |  |
`http://loinc.org` | 100524-8 | Pulmonary Outpatient Progress note |  |  |
`http://loinc.org` | 100525-5 | Radiation oncology Outpatient Progress note |  |  |
`http://loinc.org` | 100526-3 | Radiology Outpatient Progress note |  |  |
`http://loinc.org` | 100527-1 | Recreational therapy Outpatient Progress note |  |  |
`http://loinc.org` | 100528-9 | Reproductive endocrinology and infertility Outpatient Progress note |  |  |
`http://loinc.org` | 10052-9 | S wave duration in lead V1 |  |  |
`http://loinc.org` | 100529-7 | Research Outpatient Progress note |  |  |
`http://loinc.org` | 100530-5 | Rheumatology Outpatient Progress note |  |  |
`http://loinc.org` | 100531-3 | Sleep medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100532-1 | Social worker Outpatient Progress note |  |  |
`http://loinc.org` | 100533-9 | Solid Organ Transplant Outpatient Progress note |  |  |
`http://loinc.org` | 100534-7 | Speech-language pathology Outpatient Progress note |  |  |
`http://loinc.org` | 100535-4 | Spinal surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100536-2 | Sports medicine Outpatient Progress note |  |  |
`http://loinc.org` | 10053-7 | S wave duration in lead V2 |  |  |
`http://loinc.org` | 100537-0 | Surgery of the hand Outpatient Progress note |  |  |
`http://loinc.org` | 100538-8 | Telehealth+Outpatient Progress note |  |  |
`http://loinc.org` | 100539-6 | Thromboembolism Outpatient Progress note |  |  |
`http://loinc.org` | 100540-4 | Transplant surgery Outpatient Progress note |  |  |
`http://loinc.org` | 100541-2 | Trauma Outpatient Progress note |  |  |
`http://loinc.org` | 100542-0 | Urology Outpatient Progress note |  |  |
`http://loinc.org` | 100543-8 | Vascular neurology Outpatient Progress note |  |  |
`http://loinc.org` | 100544-6 | Vascular surgery Outpatient Progress note |  |  |
`http://loinc.org` | 10054-5 | S wave duration in lead V3 |  |  |
`http://loinc.org` | 100545-3 | Wound care management Outpatient Progress note |  |  |
`http://loinc.org` | 100546-1 | Wound, Ostomy, and Continence Care Outpatient Progress note |  |  |
`http://loinc.org` | 100547-9 | Adolescent medicine Hospital Progress note |  |  |
`http://loinc.org` | 100548-7 | Allergy and Immunology Hospital Progress note |  |  |
`http://loinc.org` | 100549-5 | Allergy Hospital Progress note |  |  |
`http://loinc.org` | 100550-3 | Attending Hospital Progress note |  |  |
`http://loinc.org` | 100551-1 | Audiology Hospital Progress note |  |  |
`http://loinc.org` | 10055-2 | S wave duration in lead V4 |  |  |
`http://loinc.org` | 100552-9 | Bariatric surgery Hospital Progress note |  |  |
`http://loinc.org` | 100553-7 | Blood banking and transfusion medicine Hospital Progress note |  |  |
`http://loinc.org` | 100554-5 | Bone Marrow Transplant Hospital Progress note |  |  |
`http://loinc.org` | 100555-2 | Breastfeeding Hospital Progress note |  |  |
`http://loinc.org` | 100556-0 | Burn management Hospital Progress note |  |  |
`http://loinc.org` | 100557-8 | Cardiac surgery Hospital Progress note |  |  |
`http://loinc.org` | 100558-6 | Cardiopulmonary Hospital Progress note |  |  |
`http://loinc.org` | 100559-4 | Child and adolescent psychiatry Hospital Progress note |  |  |
`http://loinc.org` | 10056-0 | S wave duration in lead V5 |  |  |
`http://loinc.org` | 100560-2 | Clinical cardiac electrophysiology Hospital Progress note |  |  |
`http://loinc.org` | 100561-0 | Clinical genetics Hospital Progress note |  |  |
`http://loinc.org` | 100562-8 | Clinical neurophysiology Hospital Progress note |  |  |
`http://loinc.org` | 100563-6 | Clinical pathology Hospital Progress note |  |  |
`http://loinc.org` | 100564-4 | Colon and rectal surgery Hospital Progress note |  |  |
`http://loinc.org` | 100565-1 | Consultant Hospital Progress note |  |  |
`http://loinc.org` | 100566-9 | Dentistry Hospital Progress note |  |  |
`http://loinc.org` | 100567-7 | Dermatology Hospital Progress note |  |  |
`http://loinc.org` | 100568-5 | Developmental-behavioral pediatrics Hospital Progress note |  |  |
`http://loinc.org` | 100569-3 | Dialysis and Therapeutic apheresis Hospital Progress note |  |  |
`http://loinc.org` | 100570-1 | Eating disorders Hospital Progress note |  |  |
`http://loinc.org` | 100571-9 | Endocrinology Hospital Progress note |  |  |
`http://loinc.org` | 100572-7 | Family medicine Hospital Progress note |  |  |
`http://loinc.org` | 100573-5 | Gastroenterology Hospital Progress note |  |  |
`http://loinc.org` | 100574-3 | General medicine Hospital Progress note |  |  |
`http://loinc.org` | 100575-0 | Geriatric medicine Hospital Progress note |  |  |
`http://loinc.org` | 100576-8 | Gynecologic oncology Hospital Progress note |  |  |
`http://loinc.org` | 100577-6 | Gynecology Hospital Progress note |  |  |
`http://loinc.org` | 10057-8 | S wave duration in lead V6 |  |  |
`http://loinc.org` | 100578-4 | Healthcare navigator Hospital Progress note |  |  |
`http://loinc.org` | 100579-2 | Heart failure Hospital Progress note |  |  |
`http://loinc.org` | 1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100580-0 | Heart failure+Transplant cardiology Hospital Progress note |  |  |
`http://loinc.org` | 100581-8 | Hematology Hospital Progress note |  |  |
`http://loinc.org` | 100582-6 | Hematology+Medical oncology Hospital Progress note |  |  |
`http://loinc.org` | 100583-4 | Hepatology Hospital Progress note |  |  |
`http://loinc.org` | 100584-2 | Immunology Hospital Progress note |  |  |
`http://loinc.org` | 100585-9 | Infectious disease Hospital Progress note |  |  |
`http://loinc.org` | 10058-6 | S' wave amplitude in lead AVF |  |  |
`http://loinc.org` | 100586-7 | Internal medicine Hospital Progress note |  |  |
`http://loinc.org` | 100587-5 | Interventional cardiology Hospital Progress note |  |  |
`http://loinc.org` | 100588-3 | Interventional radiology Hospital Progress note |  |  |
`http://loinc.org` | 100589-1 | Hospital Mechanical circulatory support Progress note |  |  |
`http://loinc.org` | 100590-9 | Medical Aid in Dying Hospital Progress note |  |  |
`http://loinc.org` | 100591-7 | Mental health Hospital Progress note |  |  |
`http://loinc.org` | 100592-5 | Multi-specialty program Hospital Progress note |  |  |
`http://loinc.org` | 100593-3 | Neonatal perinatal medicine Hospital Progress note |  |  |
`http://loinc.org` | 10059-4 | S' wave amplitude in lead AVL |  |  |
`http://loinc.org` | 100594-1 | Nephrology Hospital Progress note |  |  |
`http://loinc.org` | 100595-8 | Neurological surgery Hospital Progress note |  |  |
`http://loinc.org` | 100596-6 | Neurology Hospital Progress note |  |  |
`http://loinc.org` | 100597-4 | Neurology with special qualifications in child neurology Hospital Progress note |  |  |
`http://loinc.org` | 100598-2 | Nurse practitioner Hospital Progress note |  |  |
`http://loinc.org` | 100599-0 | Nurse Hospital Progress note |  |  |
`http://loinc.org` | 100600-6 | Nutrition and dietetics Hospital Progress note |  |  |
`http://loinc.org` | 100601-4 | Obstetrics and Gynecology Hospital Progress note |  |  |
`http://loinc.org` | 10060-2 | S' wave amplitude in lead AVR |  |  |
`http://loinc.org` | 100602-2 | Obstetrics Hospital Progress note |  |  |
`http://loinc.org` | 100603-0 | Occupational therapy Hospital Progress note |  |  |
`http://loinc.org` | 100604-8 | Oncology Hospital Progress note |  |  |
`http://loinc.org` | 100605-5 | Ophthalmology Hospital Progress note |  |  |
`http://loinc.org` | 100606-3 | Oral and Maxillofacial Surgery Hospital Progress note |  |  |
`http://loinc.org` | 100607-1 | Orthopaedic surgery Hospital Progress note |  |  |
`http://loinc.org` | 100608-9 | Orthotics prosthetics Hospital Progress note |  |  |
`http://loinc.org` | 100609-7 | Otolaryngology Hospital Progress note |  |  |
`http://loinc.org` | 10061-0 | S' wave amplitude in lead I |  |  |
`http://loinc.org` | 100610-5 | Pain medicine Hospital Progress note |  |  |
`http://loinc.org` | 100611-3 | Palliative care Hospital Progress note |  |  |
`http://loinc.org` | 100612-1 | Pastoral care Hospital Progress note |  |  |
`http://loinc.org` | 100613-9 | Pediatric cardiology Hospital Progress note |  |  |
`http://loinc.org` | 100614-7 | Pediatric dermatology Hospital Progress note |  |  |
`http://loinc.org` | 100615-4 | Pediatric endocrinology Hospital Progress note |  |  |
`http://loinc.org` | 100616-2 | Pediatric gastroenterology Hospital Progress note |  |  |
`http://loinc.org` | 100617-0 | Pediatric hematology-oncology Hospital Progress note |  |  |
`http://loinc.org` | 100618-8 | Pediatric infectious diseases Hospital Progress note |  |  |
`http://loinc.org` | 100619-6 | Pediatric otolaryngology Hospital Progress note |  |  |
`http://loinc.org` | 100620-4 | Pediatric pulmonology Hospital Progress note |  |  |
`http://loinc.org` | 100621-2 | Pediatric rheumatology Hospital Progress note |  |  |
`http://loinc.org` | 100622-0 | Pediatric surgery Hospital Progress note |  |  |
`http://loinc.org` | 100623-8 | Pediatric transplant hepatology Hospital Progress note |  |  |
`http://loinc.org` | 100624-6 | Pharmacogenomics Hospital Progress note |  |  |
`http://loinc.org` | 100625-3 | Pharmacology Hospital Progress note |  |  |
`http://loinc.org` | 100626-1 | Physical medicine and rehab Hospital Progress note |  |  |
`http://loinc.org` | 100627-9 | Physical therapy Hospital Progress note |  |  |
`http://loinc.org` | 10062-8 | S' wave amplitude in lead II |  |  |
`http://loinc.org` | 100628-7 | Plastic surgery Hospital Progress note |  |  |
`http://loinc.org` | 100629-5 | Podiatry Hospital Progress note |  |  |
`http://loinc.org` | 100630-3 | Psychology Hospital Progress note |  |  |
`http://loinc.org` | 100631-1 | Radiation oncology Hospital Progress note |  |  |
`http://loinc.org` | 100632-9 | Radiology Hospital Progress note |  |  |
`http://loinc.org` | 100633-7 | Rapid response team Hospital Progress note |  |  |
`http://loinc.org` | 100634-5 | Recreational therapy Hospital Progress note |  |  |
`http://loinc.org` | 100635-2 | Reproductive endocrinology and infertility Hospital Progress note |  |  |
`http://loinc.org` | 10063-6 | S' wave amplitude in lead III |  |  |
`http://loinc.org` | 100636-0 | Research Hospital Progress note |  |  |
`http://loinc.org` | 100637-8 | Rheumatology Hospital Progress note |  |  |
`http://loinc.org` | 100638-6 | Sleep medicine Hospital Progress note |  |  |
`http://loinc.org` | 100639-4 | Social worker Hospital Progress note |  |  |
`http://loinc.org` | 100640-2 | Solid Organ Transplant Hospital Progress note |  |  |
`http://loinc.org` | 100641-0 | Speech-language pathology Hospital Progress note |  |  |
`http://loinc.org` | 100642-8 | Spinal surgery Hospital Progress note |  |  |
`http://loinc.org` | 100643-6 | Surgery of the hand Hospital Progress note |  |  |
`http://loinc.org` | 10064-4 | S' wave amplitude in lead V1 |  |  |
`http://loinc.org` | 100644-4 | Thromboembolism Hospital Progress note |  |  |
`http://loinc.org` | 100645-1 | Trauma Hospital Progress note |  |  |
`http://loinc.org` | 100646-9 | Urology Hospital Progress note |  |  |
`http://loinc.org` | 100647-7 | Vascular neurology Hospital Progress note |  |  |
`http://loinc.org` | 100648-5 | Vascular surgery Hospital Progress note |  |  |
`http://loinc.org` | 100649-3 | Wound care management Hospital Progress note |  |  |
`http://loinc.org` | 100650-1 | Wound, Ostomy, and Continence Care Hospital Progress note |  |  |
`http://loinc.org` | 10065-1 | S' wave amplitude in lead V2 |  |  |
`http://loinc.org` | 100651-9 | Hospital COVID-19 Intubation Progress note |  |  |
`http://loinc.org` | 100652-7 | Pure tone bone conduction threshold audiometry panel |  |  |
`http://loinc.org` | 100653-5 | Deprecated Pure tone air conduction threshold audiometry panel | DEPRECATED |  |
`http://loinc.org` | 100654-3 | Pyruvate kinase M2 [Presence] in Stool |  |  |
`http://loinc.org` | 100655-0 | XR Sella turcica Lateral |  |  |
`http://loinc.org` | 100656-8 | Maternal and fetal medicine Outpatient Progress note |  |  |
`http://loinc.org` | 100657-6 | Maternal and fetal medicine Telephone encounter+Hospital Progress note |  |  |
`http://loinc.org` | 100658-4 | Hospital COVID-19 Progress note |  |  |
`http://loinc.org` | 100659-2 | Maternal and fetal medicine Hospital Progress note |  |  |
`http://loinc.org` | 1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |  |  |
`http://loinc.org` | 100660-0 | Maternal and fetal medicine Telephone encounter+Outpatient Progress note |  |  |
`http://loinc.org` | 100661-8 | Psychiatry Outpatient Progress note |  |  |
`http://loinc.org` | 100662-6 | Cortisol free and total panel - Serum or Plasma |  |  |
`http://loinc.org` | 100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 10066-9 | S' wave amplitude in lead V3 |  |  |
`http://loinc.org` | 100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |  |  |
`http://loinc.org` | 100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 10067-7 | S' wave amplitude in lead V4 |  |  |
`http://loinc.org` | 100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 10068-5 | S' wave amplitude in lead V5 |  |  |
`http://loinc.org` | 100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |  |  |
`http://loinc.org` | 100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |  |  |
`http://loinc.org` | 100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |  |  |
`http://loinc.org` | 100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |  |  |
`http://loinc.org` | 100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  |  |
`http://loinc.org` | 100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |  |  |
`http://loinc.org` | 10069-3 | S' wave amplitude in lead V6 |  |  |
`http://loinc.org` | 100693-1 | Pneumocystis jirovecii DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |  |  |
`http://loinc.org` | 100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |  |  |
`http://loinc.org` | 100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |  |  |
`http://loinc.org` | 100697-2 | Interventional radiology Outpatient Note |  |  |
`http://loinc.org` | 100698-0 | Social Determinants of Health screening report Document |  |  |
`http://loinc.org` | 100699-8 | Rifabutin+Ethambutol [Susceptibility] |  |  |
`http://loinc.org` | 100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |  |  |
`http://loinc.org` | 10070-1 | S' wave duration in lead AVF |  |  |
`http://loinc.org` | 100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |  |  |
`http://loinc.org` | 100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |  |  |
`http://loinc.org` | 100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |  |  |
`http://loinc.org` | 100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |  |  |
`http://loinc.org` | 100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |  |  |
`http://loinc.org` | 100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100707-9 | Granulocytes [#/volume] in Peritoneal dialysis fluid by Automated count |  |  |
`http://loinc.org` | 100708-7 | Plasma cells/Leukocytes in Synovial fluid |  |  |
`http://loinc.org` | 100709-5 | Hepatocellular carcinoma risk [Score] by GAAD |  |  |
`http://loinc.org` | 100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |  |  |
`http://loinc.org` | 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |  |  |
`http://loinc.org` | 100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100713-7 | Cariprazine [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100714-5 | Guanfacine [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma |  |  |
`http://loinc.org` | 100716-0 | Prostate specific Ag [Mass/volume] in DBS |  |  |
`http://loinc.org` | 100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |  |  |
`http://loinc.org` | 100718-6 | Undersea and hyperbaric medicine Discharge summary |  |  |
`http://loinc.org` | 10071-9 | S' wave duration in lead AVL |  |  |
`http://loinc.org` | 100719-4 | Surgical oncology Discharge summary |  |  |
`http://loinc.org` | 100720-2 | Reproductive endocrinology and infertility Discharge summary |  |  |
`http://loinc.org` | 100721-0 | Community health care Discharge summary |  |  |
`http://loinc.org` | 100722-8 | Integrative medicine Discharge summary |  |  |
`http://loinc.org` | 100723-6 | Sports medicine Discharge summary |  |  |
`http://loinc.org` | 100724-4 | Diabetology Discharge summary |  |  |
`http://loinc.org` | 100725-1 | Optometry Discharge summary |  |  |
`http://loinc.org` | 100726-9 | Podiatry Discharge summary |  |  |
`http://loinc.org` | 10072-7 | S' wave duration in lead AVR |  |  |
`http://loinc.org` | 100727-7 | Chiropractic medicine Discharge summary |  |  |
`http://loinc.org` | 100728-5 | Cardiac surgery Discharge summary |  |  |
`http://loinc.org` | 100729-3 | Breastfeeding Discharge summary |  |  |
`http://loinc.org` | 100730-1 | Transplant surgery Discharge summary |  |  |
`http://loinc.org` | 100731-9 | Urgent care center Discharge summary |  |  |
`http://loinc.org` | 100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |  |  |
`http://loinc.org` | 100733-5 | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |  |  |
`http://loinc.org` | 100734-3 | traMADol and Metabolites Panel - Urine by Confirmatory method |  |  |
`http://loinc.org` | 10073-5 | S' wave duration in lead I |  |  |
`http://loinc.org` | 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |  |  |
`http://loinc.org` | 100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document |  |  |
`http://loinc.org` | 100737-6 | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100738-4 | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100739-2 | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |  |  |
`http://loinc.org` | 100740-0 | Amylase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100741-8 | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100742-6 | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 10074-3 | S' wave duration in lead II |  |  |
`http://loinc.org` | 100743-4 | Lipase.macromolecular [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100744-2 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |  |  |
`http://loinc.org` | 100745-9 | Chloride [Moles/volume] in Mixed venous blood |  |  |
`http://loinc.org` | 100746-7 | Glucose [Moles/volume] in Mixed venous blood |  |  |
`http://loinc.org` | 100747-5 | Legionella serogroup panel - Specimen |  |  |
`http://loinc.org` | 100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 10075-0 | S' wave duration in lead III |  |  |
`http://loinc.org` | 100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |  |  |
`http://loinc.org` | 100752-5 | Exacerbating factors - Reported |  |  |
`http://loinc.org` | 100753-3 | Alleviating factors - Reported |  |  |
`http://loinc.org` | 100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing |  |  |
`http://loinc.org` | 100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |  |  |
`http://loinc.org` | 100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |  |  |
`http://loinc.org` | 100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |  |  |
`http://loinc.org` | 100758-2 | Estimated lung age by based on clinical data |  |  |
`http://loinc.org` | 100759-0 | Inspiratory reserve [Volume] Respiratory system by Spirometry |  |  |
`http://loinc.org` | 100760-8 | XR Radius and Ulna - left Single view |  |  |
`http://loinc.org` | 100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |  |  |
`http://loinc.org` | 100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |  |  |
`http://loinc.org` | 100763-2 | Mycobacterium sp comparative reaction interpretation Narrative |  |  |
`http://loinc.org` | 100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |  |  |
`http://loinc.org` | 100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS |  |  |
`http://loinc.org` | 100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] |  |  |
`http://loinc.org` | 100767-3 | Bothered by things that are not usually bothersome |  |  |
`http://loinc.org` | 10076-8 | S' wave duration in lead V1 |  |  |
`http://loinc.org` | 100768-1 | Poor appetite |  |  |
`http://loinc.org` | 100769-9 | Unhappy even with help from my family or friends |  |  |
`http://loinc.org` | 100770-7 | Feeling just as good as others |  |  |
`http://loinc.org` | 100771-5 | Trouble focusing |  |  |
`http://loinc.org` | 100772-3 | Feeling depressed |  |  |
`http://loinc.org` | 100773-1 | Feeling everything is too much of an effort |  |  |
`http://loinc.org` | 100774-9 | Feeling hopeful about the future |  |  |
`http://loinc.org` | 100775-6 | Feeling life had been a failure |  |  |
`http://loinc.org` | 10077-6 | S' wave duration in lead V2 |  |  |
`http://loinc.org` | 100776-4 | Feeling fearful |  |  |
`http://loinc.org` | 100777-2 | Restless sleep |  |  |
`http://loinc.org` | 100778-0 | Feeling happy |  |  |
`http://loinc.org` | 100779-8 | Quieter than usual |  |  |
`http://loinc.org` | 100780-6 | Feeling lonely |  |  |
`http://loinc.org` | 100781-4 | People were unfriendly |  |  |
`http://loinc.org` | 100782-2 | Enjoying life |  |  |
`http://loinc.org` | 100783-0 | Crying spells |  |  |
`http://loinc.org` | 10078-4 | S' wave duration in lead V3 |  |  |
`http://loinc.org` | 100784-8 | Feeling sad |  |  |
`http://loinc.org` | 100785-5 | Feeling people dislike me |  |  |
`http://loinc.org` | 100786-3 | Lack of energy |  |  |
`http://loinc.org` | 100787-1 | Total Score CES-D |  |  |
`http://loinc.org` | 100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |  |  |
`http://loinc.org` | 100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |  |  |
`http://loinc.org` | 100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |  |  |
`http://loinc.org` | 100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum |  |  |
`http://loinc.org` | 10079-2 | S' wave duration in lead V4 |  |  |
`http://loinc.org` | 100792-1 | Forsythia IgE Ab [Units/volume] in Serum |  |  |
`http://loinc.org` | 100793-9 | Testosterone [Mass/volume] in Body fluid |  |  |
`http://loinc.org` | 100794-7 | Follitropin [Units/volume] in Body fluid |  |  |
`http://loinc.org` | 100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid |  |  |
`http://loinc.org` | 100796-2 | Thyroglobulin [Mass/volume] in Body fluid |  |  |
`http://loinc.org` | 100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |  |  |
`http://loinc.org` | 10080-0 | S' wave duration in lead V5 |  |  |
`http://loinc.org` | 100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 100801-0 | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |  |  |
`http://loinc.org` | 100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |  |  |
`http://loinc.org` | 100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |  |  |
`http://loinc.org` | 100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |  |  |
`http://loinc.org` | 100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |  |  |
`http://loinc.org` | 100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |  |  |
`http://loinc.org` | 100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |  |  |
`http://loinc.org` | 100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |  |  |
`http://loinc.org` | 100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |  |  |
`http://loinc.org` | 100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |  |  |
`http://loinc.org` | 100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |  |  |
`http://loinc.org` | 100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |  |  |
`http://loinc.org` | 100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |  |  |
`http://loinc.org` | 100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |  |  |
`http://loinc.org` | 100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |  |  |
`http://loinc.org` | 10081-8 | S' wave duration in lead V6 |  |  |
`http://loinc.org` | 100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |  |  |
`http://loinc.org` | 100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |  |  |
`http://loinc.org` | 100821-8 | National POLST form: portable medical order panel |  |  |
`http://loinc.org` | 100822-6 | Cardiopulmonary resuscitation orders |  |  |
`http://loinc.org` | 100823-4 | Initial portable medical treatment orders |  |  |
`http://loinc.org` | 100824-2 | Additional portable medical orders or instructions |  |  |
`http://loinc.org` | 100825-9 | Medically assisted nutrition orders |  |  |
`http://loinc.org` | 10082-6 | ST initial amplitude 6 ms in lead AVF |  |  |
`http://loinc.org` | 100826-7 | Portable medical order AndOr advance directive review |  |  |
`http://loinc.org` | 100827-5 | Portable medical order discussion participants |  |  |
`http://loinc.org` | 100828-3 | Portable medical order administrative information |  |  |
`http://loinc.org` | 100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |  |  |
`http://loinc.org` | 100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |  |  |
`http://loinc.org` | 100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |  |  |
`http://loinc.org` | 100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |  |  |
`http://loinc.org` | 100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |  |  |
`http://loinc.org` | 10083-4 | ST initial amplitude 6 ms in lead AVL |  |  |
`http://loinc.org` | 100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |  |  |
`http://loinc.org` | 100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |  |  |
`http://loinc.org` | 100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |  |  |
`http://loinc.org` | 100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |  |  |
`http://loinc.org` | 100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |  |  |
`http://loinc.org` | 100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |  |  |
`http://loinc.org` | 100840-8 | IgE [Units/volume] in Body fluid |  |  |
`http://loinc.org` | 100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |  |  |
`http://loinc.org` | 10084-2 | ST initial amplitude 6 ms in lead AVR |  |  |
`http://loinc.org` | 100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |  |  |
`http://loinc.org` | 100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |  |  |
`http://loinc.org` | 100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |  |  |
`http://loinc.org` | 100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |  |  |
`http://loinc.org` | 100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |  |  |
`http://loinc.org` | 100847-3 | Gas and ammonia panel - Arterial blood |  |  |
`http://loinc.org` | 100848-1 | Cell count and Differential panel - Amniotic fluid by Manual count |  |  |
`http://loinc.org` | 100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count |  |  |
`http://loinc.org` | 100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count |  |  |
`http://loinc.org` | 100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count |  |  |
`http://loinc.org` | 100852-3 | NM Bones Views for metastasis W Sr-89 IV |  |  |
`http://loinc.org` | 100853-1 | NM Pericardial space Views for effusion |  |  |
`http://loinc.org` | 100854-9 | Lymphocytes/cells in Blood mononuclear cells by Immunoassay | TRIAL |  |
`http://loinc.org` | 100855-6 | CD3 cells/cells in Blood mononuclear cells | TRIAL |  |
`http://loinc.org` | 100856-4 | CD3+CD4+ (T4 helper) cells/cells in Blood mononuclear cells | TRIAL |  |
`http://loinc.org` | 100857-2 | CD3+CD8+ (T8 suppressor) cells/cells in Blood mononuclear cells | TRIAL |  |
`http://loinc.org` | 100858-0 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | TRIAL |  |
`http://loinc.org` | 10085-9 | ST initial amplitude 6 ms in lead I |  |  |
`http://loinc.org` | 100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | TRIAL |  |
`http://loinc.org` | 100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | TRIAL |  |
`http://loinc.org` | 100861-4 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | TRIAL |  |
`http://loinc.org` | 100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | TRIAL |  |
`http://loinc.org` | 100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | TRIAL |  |
`http://loinc.org` | 100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100866-3 | Febrile antibody profile in Serum |  |  |
`http://loinc.org` | 10086-7 | ST initial amplitude 6 ms in lead II |  |  |
`http://loinc.org` | 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |  |  |
`http://loinc.org` | 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |  |  |
`http://loinc.org` | 100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |  |  |
`http://loinc.org` | 100874-7 | Basidiobolus sp [Presence] in Specimen |  |  |
`http://loinc.org` | 10087-5 | ST initial amplitude 6 ms in lead III |  |  |
`http://loinc.org` | 100875-4 | Fetal Heart Document limited US |  |  |
`http://loinc.org` | 100876-2 | Fetal Heart Document US |  |  |
`http://loinc.org` | 100877-0 | US Heart Transesophageal during surgery |  |  |
`http://loinc.org` | 100878-8 | Endoscopic ultrasound study Upper GI tract Document |  |  |
`http://loinc.org` | 100879-6 | US Guidance for cryoablation of Breast - right |  |  |
`http://loinc.org` | 100880-4 | US Guidance for cryoablation of Breast - left |  |  |
`http://loinc.org` | 100881-2 | MR Guidance for cryoablation of Bone |  |  |
`http://loinc.org` | 100882-0 | MR Peritoneum W contrast percutaneous intraperitoneal |  |  |
`http://loinc.org` | 10088-3 | ST initial amplitude 6 ms in lead V1 |  |  |
`http://loinc.org` | 100883-8 | MR Guidance for biopsy of Kidney - left |  |  |
`http://loinc.org` | 100884-6 | MR Guidance for biopsy of Kidney - right |  |  |
`http://loinc.org` | 100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100888-7 | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100889-5 | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection |  |  |
`http://loinc.org` | 100890-3 | Poxvirus DNA panel |  |  |
`http://loinc.org` | 10089-1 | ST initial amplitude 6 ms in lead V2 |  |  |
`http://loinc.org` | 100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |  |  |
`http://loinc.org` | 100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |  |  |
`http://loinc.org` | 100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |  |  |
`http://loinc.org` | 100894-5 | Recommended screening frequency Narrative |  |  |
`http://loinc.org` | 100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum |  |  |
`http://loinc.org` | 100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |  |  |
`http://loinc.org` | 100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |  |  |
`http://loinc.org` | 100898-6 | Lipid panel - Serum or Plasma |  |  |
`http://loinc.org` | 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |  |  |

Explanation of the columns that may appear on this page:

Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System | The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code | The code (used as the code in the resource instance)
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition | An explanation of the meaning of the concept
Comments | Additional notes about how to use the code